We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




SEM Enables Sub-Nanometer 3D Surface Imaging

By Biotechdaily staff writers
Posted on 15 Jul 2008
An extremely high-resolution scanning electron microscope (SEM) has been launched that enables sub-nanometer three-dimensional (3D) surface imaging

The new range of SEMs will extend the range of nanoscale imaging and enable higher resolution, 3D images of carbon nanotubes, nanowires, catalysts, and semiconductors to be generated at very low beam energies.

Introduced by FEI (Hillsboro, OR, USA), the Magellan extreme high-resolution (XHR) microscope uses low energy electron beams for generating distortion-free images (high-energy beams penetrate into the material being analyzed and cause image distortions). More...
The high performance of the XHR systems derives from the integration of new electron optics, proprietary electron gun technology, a high stability platform with fully configurable analytical chamber, and a highly accurate five-axis piezo-ceramic stage that readily accommodates large samples or multiple smaller samples.

The systems can provide sub-nanometer resolution over a wide range of beam energies, from less than 1 kV to 30kV. FEI claims that this will enable manufacturers to see critical details about complex 3D structures in 32-nm nodes and below with unprecedented clarity and contrast.

The range currently comprises two models: the Magellan 400 and the Magellan 400L. "The Magellan XHR SEM is the most significant electron optics innovation since FEI introduced the Titan family three years ago,” said Dr. Rob Fastenau, FEI's executive vice president, marketing and technology. "Magellan is the only family of instruments to make sub-nanometer resolution accessible in a practical sense to non-experts and without restriction on samples--constraints that have previously limited the utility and acceptance of other systems.”


Related Links:
FEI

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
Immunofluorescence Analyzer
IFA System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A simple oral swab detected blood-matched inflammatory signals in children with primary ciliary dyskinesia, offering a needle-free way to monitor inflammation during routine care (Image credit: Shutterstock)

Simple Oral Swab Monitors Persistent Inflammation in Primary Ciliary Dyskinesia

Primary ciliary dyskinesia is a rare lung disease that affects about one in 7,500 to 10,000 live births worldwide. Symptoms can begin in the newborn period and progress to recurrent respiratory infections... Read more

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Industry

view channel
Image: The partnership aims to broaden access to ultrasensitive blood-based testing for multiple myeloma and other hematologic malignancies (Image credit: 123RF)

Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

Predicta Biosciences (Cambridge, MA, USA) and CIMA LAB Diagnostics at Clínica Universidad de Navarra (Pamplona, Spain) have entered an agreement to provide a joint service that combines CIMA LAB’s flow... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.